{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T18:27:04Z","timestamp":1787682424451,"version":"build-2784847793"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"vor","delay-in-days":66,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004214","name":"Pamukkale \u00dcniversitesi","doi-asserted-by":"publisher","award":["2018TIPF001"],"award-info":[{"award-number":["2018TIPF001"]}],"id":[{"id":"10.13039\/501100004214","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Urol"],"DOI":"10.1186\/s12894-026-02217-y","type":"journal-article","created":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T01:42:49Z","timestamp":1780882969000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Association between CYP2C19 gene polymorphisms and analgesic response to meperidine in emergency department patients with renal colic: a prospective observational study"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0145-5501","authenticated-orcid":false,"given":"Sena","family":"Baykara Sayili","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4832-0436","authenticated-orcid":false,"given":"Aylin","family":"Koseler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7425-1940","authenticated-orcid":false,"given":"Bulent","family":"Erdur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,8]]},"reference":[{"key":"2217_CR1","doi-asserted-by":"publisher","first-page":"728908","DOI":"10.3389\/fphar.2021.728908","volume":"12","author":"X-Y Leng","year":"2022","unstructured":"Leng X-Y, Liu C-N, Wang S-C, Peng H-D, Wang D-G, Pan H-F. Comparison of the efficacy of nonsteroidal anti-inflammatory drugs and opioids in the treatment of acute renal colic: a systematic review and meta-analysis. Front Pharmacol. 2022;12:728908. https:\/\/doi.org\/10.3389\/fphar.2021.728908","journal-title":"Front Pharmacol"},{"issue":"1","key":"2217_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jat\/bkt087","volume":"38","author":"KV Moy","year":"2014","unstructured":"Moy KV, Ma JD, Best BM, Atayee RS. Factors impacting variability of the urinary normeperidine-to-meperidine metabolic ratio in patients with chronic pain. J Anal Toxicol. 2014;38(1):1\u20137. https:\/\/doi.org\/10.1093\/jat\/bkt087","journal-title":"J Anal Toxicol"},{"issue":"1","key":"2217_CR3","doi-asserted-by":"publisher","first-page":"100","DOI":"10.12775\/JEHS.2023.28.01.008","volume":"28","author":"R Bakalarczyk","year":"2023","unstructured":"Bakalarczyk R, Rejmer A, Wo\u015b N, Rojek K, Bednarz L, Wijas K, et al. Acute renal colic\/renal stones\u2013problematic common disease. Current knowledge on etiology, diagnosis and treatments. J Educ Health Sport. 2023;28(1):100\u20138.","journal-title":"J Educ Health Sport"},{"issue":"7453","key":"2217_CR4","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1136\/bmj.38119.581991.55","volume":"328","author":"A Holdgate","year":"2004","unstructured":"Holdgate A, Pollock T. Systematic review of the relative efficacy of non-steroidal anti-inflammatory drugs and opioids in the treatment of acute renal colic. BMJ. 2004;328(7453):1401.","journal-title":"BMJ"},{"key":"2217_CR5","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s00240-017-0962-5","volume":"45","author":"A Trinchieri","year":"2017","unstructured":"Trinchieri A, Montanari E. Prevalence of renal uric acid stones in the adult. Urolithiasis. 2017;45:553\u201362.","journal-title":"Urolithiasis"},{"issue":"3","key":"2217_CR6","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1159\/000471700","volume":"20","author":"M Akinci","year":"1991","unstructured":"Akinci M, Esen T, Tellalo\u011flu S. Urinary stone disease in Turkey: an updated epidemiological study. Eur Urol. 1991;20(3):200\u20133.","journal-title":"Eur Urol"},{"issue":"2","key":"2217_CR7","first-page":"101","volume":"5","author":"A Trinchieri","year":"2008","unstructured":"Trinchieri A. Epidemiology of urolithiasis: an update. Clin Cases Min Bone Metab. 2008;5(2):101\u20136.","journal-title":"Clin Cases Min Bone Metab"},{"issue":"3","key":"2217_CR8","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.urology.2013.04.059","volume":"82","author":"OR Karabacak","year":"2013","unstructured":"Karabacak OR, Dilli A, Salta\u015f H, Yal\u00e7\u0131nkaya F, Y\u00f6r\u00fcko\u011flu A, Sert\u00e7elik MN. Stone compositions in Turkey: an analysis according to gender and region. Urology. 2013;82(3):532\u20138.","journal-title":"Urology"},{"key":"2217_CR9","doi-asserted-by":"crossref","unstructured":"Holdgate A, Pollock T. Nonsteroidal anti-inflammatory drugs (NSAIDs) versus opioids for acute renal colic. Cochrane Database Syst Rev. 2005;2004;(2):CD004137.","DOI":"10.1002\/14651858.CD004137.pub2"},{"issue":"3","key":"2217_CR10","first-page":"212","volume":"76","author":"J Boblewska","year":"2023","unstructured":"Boblewska J, Dybowski B. Methodology and findings of randomized clinical trials on pharmacologic and non-pharmacologic interventions to treat renal colic pain\u2013a review. Cent Eur J Urol. 2023;76(3):212\u201326.","journal-title":"Cent Eur J Urol"},{"issue":"5","key":"2217_CR11","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1089\/end.2023.0636","volume":"38","author":"RB Berman","year":"2024","unstructured":"Berman RB, Villanueva J, Margolin EJ, Balasubramanian A, Lee J, Shah O. Trends in Opioid and Nonsteroidal Anti-Inflammatory Drug Use for Patients with Kidney Stones in United States Emergency Departments from 2015 to 2021. J Endourol. 2024;38(5):458\u201365.","journal-title":"J Endourol"},{"issue":"4","key":"2217_CR12","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1007\/s40122-023-00530-0","volume":"12","author":"D Zhang","year":"2023","unstructured":"Zhang D, Liang P, Xia B, Zhang X, Hu X. Efficacy and Safety of Ketamine Versus Opiates in the Treatment of Patients with Renal Colic: A Systematic Review and Meta-analysis. Pain Ther. 2023;12(4):1079\u201393.","journal-title":"Pain Ther"},{"issue":"6","key":"2217_CR13","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/AJP.0000000000000705","volume":"35","author":"JC Finkel","year":"2019","unstructured":"Finkel JC, Pukish J. Molecular Biology of Opioid Analgesia and Its Clinical Considerations. Clin J Pain. 2019;35(6):473\u201380.","journal-title":"Clin J Pain"},{"issue":"5","key":"2217_CR14","doi-asserted-by":"publisher","first-page":"12","DOI":"10.7748\/en.14.5.12.s14","volume":"14","author":"M Kirk","year":"2006","unstructured":"Kirk M, Tonkin E. Genetics in emergency care. Emerg Nurse. 2006;14(5):12\u20136.","journal-title":"Emerg Nurse"},{"issue":"5","key":"2217_CR15","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1097\/00003643-200205000-00009","volume":"19","author":"O Eray","year":"2002","unstructured":"Eray O, \u00c7ete Y, Oktay C, Karsli B, Ak\u00e7a S, Cete N, et al. Intravenous single-dose tramadol versus meperidine for pain relief in renal colic. Eur J Anaesthesiol. 2002;19(5):368\u201370.","journal-title":"Eur J Anaesthesiol"},{"key":"2217_CR16","doi-asserted-by":"crossref","unstructured":"Tekin I, Av\u015faro\u011fullar\u0131 Ol. Comparison of the analgesic efficacy of dexketoprofen trometamol, meperidine, and paracetamol in patients presenting with renal colic. Signa Vitae. 2024;20(11):31\u20136.","DOI":"10.22514\/sv.2024.140"},{"issue":"4","key":"2217_CR17","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1097\/MJT.0b013e318274db78","volume":"21","author":"MO Ay","year":"2014","unstructured":"Ay MO, Sebe A, Kozaci N, Satar S, Acikalin A, Gulen M, et al. Comparison of the analgesic efficacy of dexketoprofen trometamol and meperidine HCl in the relief of renal colic. Am J Ther. 2014;21(4):296\u2013303.","journal-title":"Am J Ther"},{"issue":"2","key":"2217_CR18","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1017\/S1481803500004656","volume":"2","author":"VM Wood","year":"2000","unstructured":"Wood VM, Christenson JM, Innes GD, Lesperance M, McKnight RD. The NARC (nonsteroidal anti-inflammatory in renal colic) trial. Single-dose intravenous ketorolac versus titrated intravenous meperidine in acute renal colic: a randomized clinical trial. Can J Emerg Med. 2000;2(2):83\u20139.","journal-title":"Can J Emerg Med"},{"issue":"1","key":"2217_CR19","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1097\/00045391-200201000-00010","volume":"9","author":"KS Latta","year":"2002","unstructured":"Latta KS, Ginsberg B, Barkin RL. Meperidine: a critical review. Am J Ther. 2002;9(1):53\u201368.","journal-title":"Am J Ther"},{"issue":"4","key":"2217_CR20","first-page":"289","volume":"41","author":"F Wu","year":"2017","unstructured":"Wu F, Slawson MH, Johnson-Davis KL. Metabolic patterns of fentanyl, meperidine, methylphenidate, tapentadol and tramadol observed in urine, serum or plasma. J Anal Toxicol. 2017;41(4):289\u201399.","journal-title":"J Anal Toxicol"},{"issue":"4","key":"2217_CR21","doi-asserted-by":"publisher","first-page":"e00809","DOI":"10.1002\/prp2.809","volume":"9","author":"JM Boyle","year":"2021","unstructured":"Boyle JM, McCall KL, Nichols SD, Piper BJ. Declines and pronounced regional disparities in meperidine use in the United States. Pharmacol Res Perspect. 2021;9(4):e00809.","journal-title":"Pharmacol Res Perspect"},{"issue":"1","key":"2217_CR22","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s40140-023-00597-7","volume":"14","author":"WJ Binder Jr","year":"2024","unstructured":"Binder WJ Jr, Stearns JD, Gorlin AW. Parenteral Meperidine: a Review of the Pharmacology and Clinical Applications. Curr Anesthesiol Rep. 2024;14(1):131\u20138.","journal-title":"Curr Anesthesiol Rep"},{"key":"2217_CR23","doi-asserted-by":"publisher","unstructured":"JessicaL Murray, Susan L Mercer, Klarissa D Jackson, Metabolic characterization of the opioid analgesic meperidine and pharmacogenetic implications for generation of the neurotoxic metabolite normeperidine, Proceedings for Annual Meeting of The Japanese Pharmacological Society, 2018, Volume WCP2018, WCP2018 (The 18th World Congress of Basic and Clinical Pharmacology), Session ID WCP2018_PO3-14-8, Pages PO3-14-8-, Released on J-STAGE September 10, 2020, Online ISSN 2435\u20134953. https:\/\/doi.org\/10.1254\/jpssuppl.WCP2018.0_PO3-14-8","DOI":"10.1254\/jpssuppl.WCP2018.0_PO3-14-8"},{"key":"2217_CR24","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1080\/00498254.2019.1599465","volume":"50","author":"JL Murray","year":"2020","unstructured":"Murray JL, Mercer SL, Jackson KD. Impact of cytochrome P450 variation on meperidine N-demethylation to the neurotoxic metabolite normeperidine. Xenobiotica. 2020;50:209\u201322.","journal-title":"Xenobiotica"},{"issue":"2","key":"2217_CR25","first-page":"175","volume":"23","author":"SSC Wong","year":"2020","unstructured":"Wong SSC, Cheung CW. Analgesic efficacy and adverse effects of meperidine in managing postoperative or labor pain: a narrative review of randomized controlled trials. Pain Physician. 2020;23(2):175\u2013201.","journal-title":"Pain Physician"},{"issue":"4","key":"2217_CR26","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1002\/cpt.3378","volume":"116","author":"K Abouir","year":"2024","unstructured":"Abouir K, Exquis N, Gloor Y, Daali Y, Samer CF. Phenoconversion due to drug\u2013drug interactions in CYP2C19 genotyped healthy volunteers. Clin Pharmacol Ther. 2024;116(4):1121\u20139.","journal-title":"Clin Pharmacol Ther"},{"issue":"9","key":"2217_CR27","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/S0090-9556(24)02975-1","volume":"32","author":"J Ram\u00edrez","year":"2004","unstructured":"Ram\u00edrez J, Innocenti F, Schuetz EG, Flockhart DA, Relling MV, Santucci R, et al. CYP2B6, CYP3A4, and CYP2C19 are responsible for the in vitro N-demethylation of meperidine in human liver microsomes. Drug Metab Dispos. 2004;32(9):930\u20136.","journal-title":"Drug Metab Dispos"},{"issue":"1","key":"2217_CR28","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1146\/annurev.pharmtox.37.1.269","volume":"37","author":"UA Meyer","year":"1997","unstructured":"Meyer UA, Zanger UM. Molecular mechanisms of genetic polymorphisms of drug metabolism. Annu Rev Pharmacol Toxicol. 1997;37(1):269\u201396.","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"12","key":"2217_CR29","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.3390\/pharmaceutics12121191","volume":"12","author":"T Kanacher","year":"2020","unstructured":"Kanacher T, Lindauer A, Mezzalana E, Michon I, Veau C, Mantilla JDG, et al. A physiologically-based pharmacokinetic (PBPK) model network for the prediction of CYP1A2 and CYP2C19 drug\u2013drug\u2013gene interactions with fluvoxamine, omeprazole, s-mephenytoin, moclobemide, tizanidine, mexiletine, ethinylestradiol, and caffeine. Pharmaceutics. 2020;12(12):1191.","journal-title":"Pharmaceutics"},{"issue":"22","key":"2217_CR30","doi-asserted-by":"publisher","first-page":"15419","DOI":"10.1016\/S0021-9258(17)40694-6","volume":"269","author":"S De Morais","year":"1994","unstructured":"De Morais S, Wilkinson GR, Blaisdell J, Nakamura K, Meyer UA, Goldstein JA. The major genetic defect responsible for the polymorphism of S-mephenytoin metabolism in humans. J Biol Chem. 1994;269(22):15419\u201322.","journal-title":"J Biol Chem"},{"issue":"4","key":"2217_CR31","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/0009-9236(95)90053-5","volume":"58","author":"SM De Morais","year":"1995","unstructured":"De Morais SM, Goldstein JA, Xie HG, Huang SL, Lu YQ, Xia H, et al. Genetic analysis of the S-mephenytoin polymorphism in a Chinese population. Clin Pharmacol Ther. 1995;58(4):404\u201311.","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"2217_CR32","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/S0026-895X(25)09788-3","volume":"46","author":"S De Morais","year":"1994","unstructured":"De Morais S, Wilkinson GR, Blaisdell J, Meyer UA, Nakamura K, Goldstein JA. Identification of a new genetic defect responsible for the polymorphism of (S)-mephenytoin metabolism in Japanese. Mol Pharmacol. 1994;46(4):594\u20138.","journal-title":"Mol Pharmacol"},{"issue":"8","key":"2217_CR33","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1021\/bi962129k","volume":"36","author":"DM Stresser","year":"1997","unstructured":"Stresser DM, Kupfer D. Catalytic characteristics of CYP3A4: requirement for a phenolic function in ortho hydroxylation of estradiol and mono-O-demethylated methoxychlor. Biochemistry. 1997;36(8):2203\u201310.","journal-title":"Biochemistry"},{"issue":"1","key":"2217_CR34","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/S0022-3565(24)36606-6","volume":"281","author":"Z-S Xiao","year":"1997","unstructured":"Xiao Z-S, Goldstein JA, Xie H-G, Blaisdell J, Wang W, Jiang C-H, et al. Differences in the incidence of the CYP2C19Polymorphism affecting the S-mephenytoin phenotype in Chinese Han and Bai populations and identification of a new rareCYP2C19 mutant allele. J Pharmacol Exp Ther. 1997;281(1):604\u20139.","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"2217_CR35","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/S0022-3565(24)37213-1","volume":"284","author":"RJ Ferguson","year":"1998","unstructured":"Ferguson RJ, De Morais SM, Benhamou S, Bouchardy C, Blaisdell J, Ibeanu G, et al. A new genetic defect in human CYP2C19: mutation of the initiation codon is responsible for poor metabolism of S-mephenytoin. J Pharmacol Exp Ther. 1998;284(1):356\u201361.","journal-title":"J Pharmacol Exp Ther"},{"issue":"11","key":"2217_CR36","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1177\/0269881120944162","volume":"34","author":"A Singh","year":"2020","unstructured":"Singh A, Zai C, Mohiuddin AG, Kennedy JL. The pharmacogenetics of opioid treatment for pain management. J Psychopharmacol. 2020;34(11):1200\u20139.","journal-title":"J Psychopharmacol"},{"key":"2217_CR37","doi-asserted-by":"publisher","first-page":"S16","DOI":"10.1097\/AJP.0b013e3181c49e11","volume":"26","author":"CE Argoff","year":"2010","unstructured":"Argoff CE. Clinical Implications of Opioid Pharmacogenetics. Clin J Pain. 2010;26:S16\u201320.","journal-title":"Clin J Pain"},{"key":"2217_CR38","doi-asserted-by":"crossref","unstructured":"Guo YM, Zhao, ZC, Zhang L, Li, HZ, Li, Z, Sun HL. CYP2C19 polymorphisms in acute coronary syndrome patients undergoing clopidogrel therapy in Zhengzhou population. Genet Mol Res. 2016;15(2):gmr.15028012.","DOI":"10.4238\/gmr.15028012"},{"issue":"8","key":"2217_CR39","doi-asserted-by":"publisher","first-page":"587","DOI":"10.5414\/CP202490","volume":"54","author":"L Zhu","year":"2016","unstructured":"Zhu L, Liao S, Wang N, Ge T, Yang J, Xu G, et al. Dose regimens for Chinese adult liver transplant recipients according to the genetic polymorphisms of CYP2C9, CYP2C19, and CYP3A5 in recipients and donors. Int J Clin Pharmacol Ther. 2016;54(8):587.","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"1","key":"2217_CR40","doi-asserted-by":"publisher","first-page":"25478","DOI":"10.1038\/srep25478","volume":"6","author":"W-Y Zhu","year":"2016","unstructured":"Zhu W-Y, Zhao T, Xiong X-Y, Li J, Wang L, Zhou Y, et al. Association of CYP2C19 polymorphisms with the clinical efficacy of clopidogrel therapy in patients undergoing carotid artery stenting in Asia. Sci Rep. 2016;6(1):25478.","journal-title":"Sci Rep"},{"issue":"3","key":"2217_CR41","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1001\/jamapsychiatry.2020.3643","volume":"78","author":"F Milosavljevi\u0107","year":"2021","unstructured":"Milosavljevi\u0107 F, Bukvi\u0107 N, Pavlovi\u0107 Z, Miljevi\u0107 \u010c, Pe\u0161i\u0107 V, Molden E, et al. Association of CYP2C19 and CYP2D6 poor and intermediate metabolizer status with antidepressant and antipsychotic exposure: a systematic review and meta-analysis. JAMA psychiatry. 2021;78(3):270\u201380.","journal-title":"JAMA psychiatry"},{"issue":"3","key":"2217_CR42","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1111\/j.1365-2125.2009.03578.x","volume":"69","author":"A Li-Wan\u2010Po","year":"2010","unstructured":"Li-Wan\u2010Po A, Girard T, Farndon P, Cooley C, Lithgow J. Pharmacogenetics of CYP2C19: functional and clinical implications of a new variant CYP2C19* 17. Br J Clin Pharmacol. 2010;69(3):222\u201330.","journal-title":"Br J Clin Pharmacol"},{"issue":"9","key":"2217_CR43","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1016\/j.jcin.2020.03.034","volume":"13","author":"S Calcagno","year":"2020","unstructured":"Calcagno S, Di Pietro R, Biondi-Zoccai G, Versaci F. Do We Really Need Routine CYP2C19 Genotyping? JACC Cardiovasc Interv. 2020;13(9):1134\u20135.","journal-title":"JACC Cardiovasc Interv"},{"key":"2217_CR44","doi-asserted-by":"publisher","first-page":"1542000","DOI":"10.3389\/fpsyt.2025.1542000","volume":"16","author":"M Hatano","year":"2025","unstructured":"Hatano M, Ikeda M, Saito T, Miyata M, Iwata N, Yamada S. Estimating the incidence of actionable drug-gene interactions in Japanese patients with major depressive disorder. Front Psychiatry. 2025;16:1542000.","journal-title":"Front Psychiatry"},{"issue":"11","key":"2217_CR45","doi-asserted-by":"publisher","first-page":"619","DOI":"10.31083\/ph.2018.8689","volume":"73","author":"B Sienkiewicz-Oleszkiewicz","year":"2018","unstructured":"Sienkiewicz-Oleszkiewicz B, Wiela-Hoje\u0144ska A. CYP2C19 polymorphism in relation to the pharmacotherapy optimization of commonly used drugs. Pharmazie. 2018;73(11):619\u201324.","journal-title":"Pharmazie"},{"key":"2217_CR46","doi-asserted-by":"crossref","unstructured":"Gareeva AE, Borodina LS, Pozdnyakov SA, Timerbulatov IF. Pharmacogenomic and pharmacometabolomic biomarkers of the efficacy and safety of antidepressants: focus on selective serotonin reuptake inhibitors. S.S. Zh Nevrol Psikhiatr Im S S Korsakova 2024;124(6):26\u201335. (In Russ.)","DOI":"10.17116\/jnevro202412406126"},{"key":"2217_CR47","doi-asserted-by":"crossref","unstructured":"Da Rocha Zurchimitten G, Camerini L, Iz\u00eddio GS, Ghisleni G. Identifying genetic variants associated with side effects of antidepressant treatment: A systematic review. Prog Neuropsychopharmacol Biol Psychiatry. 2025;136:111154.","DOI":"10.1016\/j.pnpbp.2024.111154"},{"issue":"1","key":"2217_CR48","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/s41398-024-03064-x","volume":"14","author":"L Danyang","year":"2024","unstructured":"Danyang L, Pain O, Fabbri C, Wong WLE, Chris Wai Hang L, Ripke S, et al. Correction: Metabolic activity of CYP2C19 and CYP2D6 on antidepressant response from 13 clinical studies using genotype imputation: a meta-analysis. Transl Psychiatry. 2024;14(1):296.","journal-title":"Transl Psychiatry"},{"issue":"1","key":"2217_CR49","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1002\/cpt.597","volume":"102","author":"JK Hicks","year":"2017","unstructured":"Hicks JK, Sangkuhl K, Swen JJ, Ellingrod VL, M\u00fcller DJ, Shimoda K, et al. Clinical pharmacogenetics implementation consortium guideline (CPIC\u00ae) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update. Clin Pharmacol Ther. 2017;102(1):37\u201344.","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"2217_CR50","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1002\/cpt.1973","volume":"109","author":"MR Botton","year":"2021","unstructured":"Botton MR, Whirl-Carrillo M, Del Tredici AL, Sangkuhl K, Cavallari LH, Ag\u00fandez JA, et al. PharmVar GeneFocus: CYP2C19. Clin Pharmacol Ther. 2021;109(2):352\u201366.","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"2217_CR51","doi-asserted-by":"publisher","first-page":"28","DOI":"10.2133\/dmpk.DMPK-12-RV-085","volume":"28","author":"T Hirota","year":"2013","unstructured":"Hirota T, Eguchi S, Ieiri I. Impact of genetic polymorphisms in CYP2C9 and CYP2C19 on the pharmacokinetics of clinically used drugs. Drug Metab Pharmacokinet. 2013;28(1):28\u201337.","journal-title":"Drug Metab Pharmacokinet"},{"issue":"1","key":"2217_CR52","doi-asserted-by":"publisher","first-page":"70","DOI":"10.17749\/2077-8333\/epi.par.con.2025.240","volume":"17","author":"N Galankin","year":"2025","unstructured":"Galankin N, Tadtaeva Z, Sardaryan I, Galustyan A, Gromova O. Impact of CYP2C9, CYP2C19 and ABCB1 genetic polymorphisms on antiepileptic drug safety and efficacy. Epilepsy paroxysmal conditions. 2025;17(1):70\u201381.","journal-title":"Epilepsy paroxysmal conditions"},{"issue":"2","key":"2217_CR53","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/tpj.2015.70","volume":"16","author":"I Fricke-Galindo","year":"2016","unstructured":"Fricke-Galindo I, C\u00e9spedes-Garro C, Rodrigues-Soares F, Naranjo M, Delgado A, De Andr\u00e9s F, et al. Interethnic variation of CYP2C19 alleles,\u2018predicted\u2019phenotypes and \u2018measured\u2019metabolic phenotypes across world populations. Pharmacogenomics J. 2016;16(2):113\u201323.","journal-title":"Pharmacogenomics J"},{"issue":"2","key":"2217_CR54","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1053\/cp.1999.v66.100072001","volume":"66","author":"AS Aynacioglu","year":"1999","unstructured":"Aynacioglu AS, Sachse C, Bozkurt A, Kortunay S, Nacak M, Schr\u00f6der T, et al. Low frequency of defective alleles of cytochrome P450 enzymes 2C19 and 2D6 in the Turkish population. Clin Pharmacol Ther. 1999;66(2):185\u201392.","journal-title":"Clin Pharmacol Ther"},{"key":"2217_CR55","doi-asserted-by":"publisher","first-page":"53","DOI":"10.4274\/BMB.galenos.2020.08.040","volume":"6","author":"R Sab\u0131rl\u0131","year":"2021","unstructured":"Sab\u0131rl\u0131 R, K\u00f6seler A, Y\u0131lmaz A, K\u0131l\u0131\u00e7 \u0130D. CYP2C19* 1 and CYP2C19* 2 polymorphism in Turkish patients being diagnosed with stable coronary artery disease and using clopidogrel. Bagcilar Med Bull. 2021;6:53\u201360.","journal-title":"Bagcilar Med Bull"},{"issue":"9","key":"2217_CR56","doi-asserted-by":"publisher","first-page":"E257","DOI":"10.5489\/cuaj.8283","volume":"17","author":"ET Keskin","year":"2023","unstructured":"Keskin ET, Bozkurt M, \u00d6zdemir H, U\u011fur R, Savun M, \u00d6zdemir M\u015e, et al. The severity of renal colic pain: Can it be predicted? Can Urol Assoc J. 2023;17(9):E257\u201362.","journal-title":"Can Urol Assoc J"},{"key":"2217_CR57","doi-asserted-by":"crossref","unstructured":"Joshi SS, Kaeley N, Nagasubramanyam V, Sharma P, Raj A. RAJ A. Correlation of severity of renal colic with clinical, laboratory, and radiological parameters: an emergency department-based prospective observational study. Cureus. 2022;14(11):e31277.","DOI":"10.7759\/cureus.31277"},{"key":"2217_CR58","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ajem.2021.02.049","volume":"45","author":"K Gourlay","year":"2021","unstructured":"Gourlay K, Splinter G, Hayward J, Innes G. Does pain severity predict stone characteristics or outcomes in emergency department patients with acute renal colic? Am J Emerg Med. 2021;45:37\u201341.","journal-title":"Am J Emerg Med"},{"issue":"S1","key":"2217_CR59","doi-asserted-by":"publisher","first-page":"S45","DOI":"10.1017\/cem.2020.158","volume":"22","author":"G Splinter","year":"2020","unstructured":"Splinter G, Gourlay K, Hayward J, Innes G. MP10: Does arrival pain severity predict stone characteristics or short-term outcomes in emergency department patients with acute renal colic? CJEM. 2020;22(S1):S45\u20136.","journal-title":"CJEM"},{"issue":"11","key":"2217_CR60","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1016\/j.ajem.2019.06.013","volume":"37","author":"M\u0130 Sasmaz","year":"2019","unstructured":"Sasmaz M\u0130, Kirpat V. The relationship between the severity of pain and stone size, hydronephrosis and laboratory parameters in renal colic attack. Am J Emerg Med. 2019;37(11):2107\u201310.","journal-title":"Am J Emerg Med"},{"issue":"181","key":"2217_CR61","first-page":"138","volume":"29","author":"M Hoseininejad","year":"2020","unstructured":"Hoseininejad M, Hasannejad R, Mousavi J, Jahanian F, Rezaimehr B, Aminiahidashti H. One-month Clinical and Paraclinical Evaluation of Patients with Renal Colic. J Mazandaran Univ Med Sci. 2020;29(181):138\u201343.","journal-title":"J Mazandaran Univ Med Sci"},{"issue":"9","key":"2217_CR62","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1097\/AJP.0b013e31821d8ac1","volume":"27","author":"HS Smith","year":"2011","unstructured":"Smith HS. The Metabolism of Opioid Agents and the Clinical Impact of Their Active Metabolites. Clin J Pain. 2011;27(9):824\u201338.","journal-title":"Clin J Pain"},{"issue":"10374","key":"2217_CR63","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/S0140-6736(22)01841-4","volume":"401","author":"JJ Swen","year":"2023","unstructured":"Swen JJ, van der Wouden CH, Manson LE, Abdullah-Koolmees H, Blagec K, Blagus T, et al. A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study. Lancet. 2023;401(10374):347\u201356.","journal-title":"Lancet"},{"key":"2217_CR64","doi-asserted-by":"publisher","first-page":"1189976","DOI":"10.3389\/fphar.2023.1189976","volume":"14","author":"D Kabbani","year":"2023","unstructured":"Kabbani D, Akika R, Wahid A, Daly AK, Cascorbi I, Zgheib NK. Pharmacogenomics in practice: a review and implementation guide. Front Pharmacol. 2023;14:1189976.","journal-title":"Front Pharmacol"}],"container-title":["BMC Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12894-026-02217-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-026-02217-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-026-02217-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T04:16:14Z","timestamp":1786594574000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12894-026-02217-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,8]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2217"],"URL":"https:\/\/doi.org\/10.1186\/s12894-026-02217-y","relation":{},"ISSN":["1471-2490"],"issn-type":[{"value":"1471-2490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,8]]},"assertion":[{"value":"16 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by Pamukkale University, Non-Invasive Clinical Research Ethics Committee (24.05.2017-60116787-020\/33092). Written and verbally informed consent was obtained from each individual. All procedures followed were in accordance with the ethical standards of the committee responsible for human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"200"}}